71
Views
4
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

A novel ruthenium(II)–polypyridyl complex inhibits cell proliferation and induces cell apoptosis by impairing DNA damage repair

, , &

References

  • Rosenberg B, VanCamp L, Trosko JE, Mansour VH. Platinum compounds: a new class of potent antitumour agents. Nature. 1969;222(5191):385–6.
  • Galanski M, Jakupec MA, Keppler BK. Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches. Curr Med Chem. 2005;12(18):2075–94.
  • Sandler A, Graham C, Baggstrom M, Herbst R, Zergebel C, Saito K, et al. An open-label, multicenter, three-stage, phase II study of s-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer. J Thorac Oncol. 2011;6(8):1400–6.
  • Xu L, Xie YY, Zhong NJ, Liang ZH, He J, Huang HL, et al. DNA-binding and photocleavage, cytotoxicity, apoptosis and antioxidant activity studies of ruthenium(II) complexes. Trans Met Chem. 2012;37(2):197–205.
  • Morris RE, del Socorro Murdoch P, Chen HM, Cummings J, Hughes ND, Parsons S, et al. Jodrell,and Peter J. Sadler. Inhibition of cancer cell growth by ruthenium(II) arene complexes. J Med Chem. 2001;44(22):3616–21.
  • Clarke MJ, Bitler S, Rennert D, Buchbinder M, Kelman AD. Reduction and subsequent binding of ruthenium ions catalyzed by subcellular components. J Inorg Biochem. 1980;12(1):79–87.
  • Dougan SJ, Habtemariam A, McHale SE, Parsons S, Sadler PJ. Catalytic organometallic anticancer complexes. Proc Natl Acad Sci USA. 2008;105(33):11628–33.
  • Choudhury TY, Choudhury SA. DNA repair protein: endo-exonuclease as a new frontier in cancer therapy. Future Oncol. 2005;1(2):265–71.
  • Darzynkiewicz Z, Targanos F, Wlodkowic D. Impaired DNA damage response — an Achilles’ heel sensitizing cancer to chemotherapy and radiotherapy. Eur J Pharmacol 2009;625(1–3):143–50.
  • Asakawa H, Koizumi H, Koike A, Takahashi M, Wu W, Iwase H, et al. Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins. Breast Cancer Res. 2010;12(2):R17.
  • Dickeson JE, Summers LA. Chemical constitution and activity of bipyridylium herbicides. V. Diquaternary salts of trans-1,2-Di-(4-pyridyl)ethylene. J Chem Soc Perkin 1. 1969;12:1643–5.
  • Liu J, Zou XH, Zhang QL, Mei WJ, Liu JZ, Ji LN. Synthesis, characterization and antitumor activity of a series of polypyridyl complexes. Met Based Drugs. 2000;7(6):343–8.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.
  • Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000;35(3):206–21.
  • Laine AL, Passirani C. Novel metal-based anticancer drugs: a new challenge in drug delivery. Curr Opin Pharmacol. 2012;12(4):420–6.
  • Lovell DP, Omori T. Statistical issues in the use of the comet assay. Mutagenesis. 2008;23(3):171–82.
  • Fernandez-Capetillo O, Celeste A, Nussenzweig A. Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell Cycle. 2003;2(5):426–7.
  • Warbrick E. The puzzle of PCNA’s many partners. Bioessays. 2000;22(11):997–1006.
  • Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci. 2003;116(Pt 15):3051–60.
  • Szüts D, Christov C, Kitching L, Krude T. Distinct populations of human PCNA are required for initiation of chromosomal DNA replication and concurrent DNA repair. Exp Cell Res. 2005;311(2):240–50.
  • Huen MS, Grant R, Manke I, Minn K, Yu X, Yaffe MB, et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell. 2007;131(5):901–14.
  • Yan J, Jetten AMRAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites. Cancer Lett. 2008;271(2):179–90.
  • Kasparkova J, Suchankova T, Halamikova A, Zerzankova L, Vrana O, Margiotta N, et al. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring PtII chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand. Biochem Pharmacol. 2010;79(4):552–64.
  • Du F, Qian ZM, Zhu L, Wu XM, Yung WH, Tsim TY, et al. L-DOPA neurotoxicity is mediated by up-regulation of DMT1-IRE expression. Plos ONE. 2009;4(2):e4593.
  • Chan YS, Wong JH, Fang EF, Pan W, Ng TB. Isolation of a glucosamine binding leguminous lectin with mitogenic activity towards splenocytes and anti-proliferative activity towards tumor cells. Plos ONE. 2012;7(6):e38961.
  • Yook JI, Kim J. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppresso r gene status in oral squamous cell carcinomas. Oral Oncol. 1998;34(3):198–203.
  • Zhang G, Wu C, Ye H, Yan H, Wang X. Nanoscaled carborane ruthenium(II)-arene complex inducing lung cancer cells apoptosis. J. Nanobiotechnol. 2011;9(1):6.
  • Beck DJ, Brubaker RR. Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli. J Bacteriol. 1973;116(3):1247–52.
  • Brouwer J, van de Putte P, Fichtinger-Schepman AM, Reedijk J. Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II). Proc Natl Acad Sci USA. 1981;78(11):7010–4.
  • Beck DJ, Popoff S, Sancar A, Rupp WD. Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II). Nucleic Acids Res. 1985;13(20):7395–412.
  • Al-Hakim A, Escribano-Diaz C, Landry MC, O’Donnell L, Panier S, Szilard RK, et al. The ubiquitous role of ubiquitin in the DNA damage response. DNA Repair. 2010;9(12):1229–40.
  • Zhang F, Brick G, Park JY, Andreassen PR. MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination. J Cell Sci. 2012;125(Pt24):6049–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.